Calidi Biotherapeutics, Inc (CLDI) insider trading

Every open-market stock purchase and sale by Calidi Biotherapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $1.2K over the last 12 months (1 sale). No open-market buys.
  • Last insider buy: Scott Leftwich (Director), $250K, 14 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $1.2K (1 sale). Last close $0.77 on Oct 21, 2026.

Recent CLDI insider trades

DateInsiderTradeValue
Aug 17, 2026Eric E Poma (CEO)Bought (not open market)$43.5K
Aug 17, 2026Santidrian Antonio Fernandez (C-suite exec)Bought (not open market)$21.8K
Aug 17, 2026Andrew C. Jackson (CFO)Bought (not open market)$19K
Aug 17, 2026James A Schoeneck (Director)Bought (not open market)—
Aug 17, 2026George Peoples (Director)Bought (not open market)—
Aug 17, 2026Corazon (Corsee) D. Sanders (Director)Bought (not open market)—
Aug 17, 2026Alan R. Stewart (Director)Bought (not open market)—
Aug 17, 2026Scott Leftwich (Director)Bought (not open market)—
Dec 12, 2025Allan Camaisa (Director)Sold$1.2K

Who's trading CLDI

Get free alerts when an insider at Calidi Biotherapeutics, Inc files a new trade →